Literature DB >> 29265955

Challenges to Developing a Rotavirus Vaccine.

Paul A Offit1.   

Abstract

Rotavirus is the most important cause of gastroenteritis worldwide. In developing countries, the virus is a major cause of death in infants and young children. In the United States, before the licensure of vaccines, rotavirus infections accounted for ∼2.7 million cases of gastroenteritis annually. Here are described the history and challenges surrounding the development of a rotavirus vaccine.

Entities:  

Keywords:  gastroenteritis; rotavirus; vaccine development

Mesh:

Substances:

Year:  2017        PMID: 29265955     DOI: 10.1089/vim.2017.0121

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  6 in total

1.  Dengue vaccines: the road to failure or to success?

Authors:  Stanley A Plotkin
Journal:  Hum Vaccin Immunother       Date:  2020-05-19       Impact factor: 3.452

2.  Vaccination of pregnant rhesus monkeys with inactivated rotavirus as a model for achieving protection from rotavirus SA11 infection in the offspring.

Authors:  Na Yin; Jinyuan Wu; Xiangjing Kuang; Xiaochen Lin; Yan Zhou; Shan Yi; Xiaoqing Hu; Rong Chen; Yaling Liu; Jun Ye; Zhanlong He; Maosheng Sun; Hongjun Li
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

Review 3.  Role of Microbiota in Viral Infections and Pathological Progression.

Authors:  Taketoshi Mizutani; Aya Ishizaka; Michiko Koga; Takeya Tsutsumi; Hiroshi Yotsuyanagi
Journal:  Viruses       Date:  2022-05-01       Impact factor: 5.818

Review 4.  The Rotavirus Vaccine Landscape, an Update.

Authors:  Roberto Cárcamo-Calvo; Carlos Muñoz; Javier Buesa; Jesús Rodríguez-Díaz; Roberto Gozalbo-Rovira
Journal:  Pathogens       Date:  2021-04-26

Review 5.  Viral Infections, the Microbiome, and Probiotics.

Authors:  Ashton Harper; Vineetha Vijayakumar; Arthur C Ouwehand; Jessica Ter Haar; David Obis; Jordi Espadaler; Sylvie Binda; Shrilakshmi Desiraju; Richard Day
Journal:  Front Cell Infect Microbiol       Date:  2021-02-12       Impact factor: 6.073

6.  Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency.

Authors:  David McAdams; Marcus Estrada; David Holland; Jasneet Singh; Nishant Sawant; John M Hickey; Prashant Kumar; Brian Plikaytis; Sangeeta B Joshi; David B Volkin; Robert Sitrin; Stan Cryz; Jessica A White
Journal:  Vaccine       Date:  2022-07-22       Impact factor: 4.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.